Brighton Jones LLC lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 19.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,842 shares of the semiconductor company’s stock after selling 1,673 shares during the period. Brighton Jones LLC’s holdings in Synopsys were worth $2,976,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Synopsys during the 2nd quarter valued at about $7,228,099,000. Van ECK Associates Corp increased its stake in Synopsys by 19.7% during the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock worth $1,542,175,000 after purchasing an additional 569,687 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Synopsys by 40.7% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock worth $1,377,174,000 after purchasing an additional 892,736 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Synopsys by 11.2% during the 3rd quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock worth $1,187,381,000 after purchasing an additional 274,586 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in Synopsys during the 2nd quarter worth approximately $747,400,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Synopsys from $475.00 to $540.00 and gave the company an “overweight” rating in a research note on Thursday, October 1st. Rothschild & Co Redburn reduced their price target on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating for the company in a report on Wednesday, September 23rd. Needham & Company LLC increased their price objective on shares of Synopsys from $580.00 to $620.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. Morgan Stanley raised their price objective on shares of Synopsys from $500.00 to $574.00 and gave the stock an “overweight” rating in a report on Tuesday, October 20th. Finally, UBS Group set a $570.00 price objective on shares of Synopsys in a report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $575.00.
Read Our Latest Report on Synopsys
Synopsys Stock Performance
NASDAQ SNPS opened at $466.97 on Tuesday. The firm has a market capitalization of $89.49 billion, a P/E ratio of 82.50, a price-to-earnings-growth ratio of 1.47 and a beta of 1.18. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The firm’s fifty day moving average price is $442.10 and its two-hundred day moving average price is $442.00. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company’s quarterly revenue was up 42.4% on a year-over-year basis. During the same quarter last year, the firm posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts anticipate that Synopsys, Inc. will post 11.01 EPS for the current year.
Synopsys declared that its Board of Directors has authorized a stock buyback plan on Monday, October 5th that authorizes the company to buy back $1 billion in shares. This repurchase authorization authorizes the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Share repurchase plans are usually a sign that the company’s management believes its shares are undervalued.
Insiders Place Their Bets
In other news, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the completion of the transaction, the insider directly owned 120,443 shares in the company, valued at approximately $50,518,611.92. The trade was a 16.98% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $462.84, for a total value of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares in the company, valued at $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 117,163 shares of company stock valued at $51,366,457. Corporate insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs.
The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Featured Stories
- Five stocks we like better than Synopsys
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
